|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.11 INR | +0.15% |
|
-0.22% | -1.45% |
| Market Cap | 439M 4.6M 4M 3.72M 3.42M 6.45M 6.55M 43.87M 17.22M 219M 17.27M 16.89M 733M | P/E 2024 |
-16.2x | P/E 2025 | 17.5x |
|---|---|---|---|---|---|
| Enterprise Value | 1.38B 14.41M 12.53M 11.66M 10.7M 20.21M 20.53M 137M 53.94M 685M 54.11M 52.93M 2.3B | EV / Sales 2024 |
0.69x | EV / Sales 2025 | 0.66x |
| Free-Float |
62.31% | Yield 2024 * |
-
| Yield 2025 | - |
| 22-02-04 | Mangalam Drugs & Organics : Resignation | PU |
| 1 day | +0.15% | ||
| 1 week | -0.22% | ||
| Current month | -3.66% | ||
| 1 month | -3.66% | ||
| 3 months | -8.04% | ||
| 6 months | -25.11% | ||
| Current year | -1.45% |
| 1 week | 26.33 |  | 27.8 |
| 1 month | 26.33 | | 29.3 |
| Current year | 26.33 | | 54.4 |
| 1 year | 22.8 | | 90.85 |
| 3 years | 22.8 | | 144.99 |
| 5 years | 22.8 | | 194.15 |
| 10 years | 20.65 | | 225.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 72 | 2011-09-29 | |
| Director of Finance/CFO | - | 2026-02-05 | |
Shweta Patel
CMP | Compliance Officer | 27 | 2026-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 2010-02-01 | |
| Director/Board Member | 75 | 2015-02-04 | |
Nidhi S. Mundada
BRD | Director/Board Member | 37 | 2018-05-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.15% | -0.22% | - | - | 4.48M | |
| -0.53% | +1.87% | +14.81% | +74.83% | 50.29B | |
| -1.81% | +1.69% | +53.40% | +106.05% | 37.24B | |
| +0.46% | +5.76% | -5.53% | +25.08% | 12.41B | |
| +1.05% | +1.17% | +13.23% | +75.93% | 11.65B | |
| -1.14% | +0.57% | +32.24% | +132.30% | 9.17B | |
| -2.99% | -0.60% | +43.05% | -8.54% | 7.24B | |
| +0.51% | +1.29% | +14.45% | +34.63% | 6.8B | |
| +1.99% | +1.31% | +3.73% | +179.67% | 6.47B | |
| +0.39% | -4.81% | -34.14% | -1.07% | 5.46B | |
| Average | -0.19% | +1.96% | +15.03% | +68.76% | 16.3B | |
| Weighted average by Cap. | -0.61% | +2.71% | +22.91% | +78.05% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.67B 38.48M 33.45M 31.14M 28.59M 53.99M 54.82M 367M 144M 1.83B 145M 141M 6.13B | 3.18B 33.27M 28.92M 26.92M 24.71M 46.67M 47.39M 317M 125M 1.58B 125M 122M 5.3B |
| Net income | -90.72M -950K -826K -769K -706K -1.33M -1.35M -9.06M -3.56M -45.16M -3.57M -3.49M -151M | 67.21M 704K 612K 570K 523K 988K 1M 6.71M 2.64M 33.46M 2.64M 2.59M 112M |
| Net Debt | 1.06B 11.08M 9.63M 8.97M 8.23M 15.55M 15.79M 106M 41.49M 527M 41.63M 40.71M 1.77B | 936M 9.81M 8.53M 7.94M 7.29M 13.76M 13.97M 93.56M 36.72M 466M 36.84M 36.03M 1.56B |
Employees
480
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | ₹27.11 | +0.15% | 8,754 |
| 26-07-30 | ₹27.07 | -0.26% | 24,198 |
| 26-07-29 | ₹27.14 | -1.17% | 25,640 |
| 26-07-28 | ₹27.46 | +0.15% | 18,804 |
| 26-07-27 | ₹27.42 | +0.73% | 8,630 |
- Stock Market
- Stocks
- MANGALAM Stock
- MANGALAM Stock
Select your edition
All financial news and data tailored to specific country editions
